BeiGene Ltd. Financial Flexibility Index
BeiGene Ltd. financial flexibility index. BeiGene Ltd. (49B) has a Financial Flexibility Index of 0.07x as of March 2025. Free cash flow of €160.49 Million (operating CF €44.08 Million minus capex €116.41 Million) represents 0% of total liabilities (€2.34 Billion). See free cash flow generation of BeiGene Ltd. to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of BeiGene Ltd. (2016–2024)
Financial flexibility index of BeiGene Ltd. from 2016 to 2024. Historical Financial Flexibility Index trend for BeiGene Ltd. across 9 annual periods. Check 49B cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
BeiGene Ltd. Financial Flexibility Index by Year (2016–2024)
BeiGene Ltd. financial flexibility index by year from 2016 to 2024. Year-by-year free cash flow to debt coverage for BeiGene Ltd.. For the full cash flow conversion analysis, see 49B operating cash flow.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.15x | €388.51 Million | €-140.63 Million | €2.59 Billion | ▲ +152.0% |
| 2023 | -0.29x | €-654.63 Million | €-1.25 Billion | €2.27 Billion | ▲ +50.8% |
| 2022 | -0.59x | €-1.17 Billion | €-1.50 Billion | €2.00 Billion | ▼ -36.1% |
| 2021 | -0.43x | €-1.04 Billion | €-1.30 Billion | €2.40 Billion | ▲ +36.0% |
| 2020 | -0.67x | €-1.17 Billion | €-1.28 Billion | €1.73 Billion | ▲ +35.4% |
| 2019 | -1.04x | €-660.66 Million | €-750.27 Million | €633.93 Million | ▼ -8.3% |
| 2018 | -0.96x | €-477.43 Million | €-547.72 Million | €496.04 Million | ▼ -689.7% |
| 2017 | 0.16x | €59.13 Million | €12.75 Million | €362.25 Million | ▲ +113.1% |
| 2016 | -1.25x | €-66.01 Million | €-89.51 Million | €52.91 Million | — |